Alarming prevalence of fetal alcohol exposure in a Mediterranean city

Therapeutic Drug Monitoring

Volumn 30, Issue 2, 2008, Pages 249-254

  Garcia Algar, Oscar ^a   Kulaga, Vivan ^b   Gareri, Joey ^b   Koren, Gideon ^b   Vall, Oriol ^a   Zuccaro, Piergiorgio ^c   Pacifici, Roberta ^c   Pichini, Simona ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Fatty acid ethyl esters; Fetal alcohol exposure; Meconium

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; FATTY ACID ESTER; OPIATE;

ADULT; ALCOHOL CONSUMPTION; CHEMICAL ANALYSIS; CONFERENCE PAPER; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MECONIUM; PREGNANCY; PRIORITY JOURNAL; SOCIOECONOMICS;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; COHORT STUDIES; ESTERS; FATTY ACIDS; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MECONIUM; MEDITERRANEAN REGION; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; SPAIN; SUBSTANCE ABUSE DETECTION;

EID: 42049110334     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31816a8657     Document Type: Conference Paper

References (21)

1. Abel EL. Fetal Alcohol Syndrome: From Mechanism to Prevention. Boca Raton, FL: CRC Press; 1996.
2. Bearer CF. Markers to detect drinking during pregnancy. Alcohol Res Health, 2001;25:210-218.
3. Klein J, Karaskov T, Koren G. Fatty acid ethyl esters: a novel biologic marker for heavy in utero ethanol exposure: a case report. Ther Drug Monit. 1999;21:644-646.
4. Bearer CF, Jacobson JL, Jacobson SW, et al. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 2003;143:463-469.
5. Chan D, Caprara D, Blanchette P, et al. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem. 2004;37:429-438.
6. Moore C, Jones J, Lewis D, et al. Prevalence of fatty acid ethyl esters in meconium specimens. Clin Chem. 2003;49:133-136.
7. Ostrea EM, Hernandez JD, Bielawski DM, et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res. 2006;30;1152-1159.
8. Greenbaum R, Nulman I, Rovet J, et al. The Toronto experience in diagnosing alcohol-related neurodevelopmental disorder: a unique profile of deficits and assets. Can J Clin Pharmacol. 2002;9:215-225.
9. Burd L, Klug MG, Martsolf JT, et al. Fetal alcohol syndrome: neuropsychiatric phenomics. Neurotoxicol Teratol. 2003;2:697-705.
10. Nash K, Rovet J, Greenbaum R, et al. Identifying the behavioural phenotype in fetal alcohol spectrum disorder: sensitivity, specificity and screening potential. Arch Womens Ment Health. 2006;9:181-186.
11. Pichini S, Puig C, Zuccaro P, et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project." Forensic Sci Int. 2005;153:59-65.
12. Lozano J, García-Algar O, Marchei E, et al. Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr. 2007;96:1734-1737.
13. Informe 2004 del Observatorio Español Sobre Drogas. Available at: http://www.pnsd.msc.es/Categoria2/publica/pdf/oed-2004.pdf. Accessed September 2006.
14. Chan D, Bar-Oz B, Pellerin B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003;25:271-278.
15. US department of Health and Human Services, Food and Drug Administration. Guidance for industry, bioanalytical method validation, May 2001, Available at: http://www.fda.gov/cder/guidance/4252fnl.htm. Accessed December 2007.
16. Chan D, Klein J, Karaskov T, et al. Fetal exposure to alcohol as evidenced by fatty acid ethyl esters in meconium in absence of maternal drinking history in pregnancy. Ther Drug Monit. 2004;26: 474-481.
17. Koren G, Nulman I, Chudley AE, et al. Fetal alcohol spectrum disorder. CMAJ. 2003;169:1181-1185.
18. Gareri J, Klein J, Koren G. Drugs of abuse testing in meconium. Clin Chim Acta. 2006;366:101-111.
19. Lemoine P, Harousseau H, Borteyru J-P, et al. Les enfants de parents alcooliques: anomalies observees. A propos de 127 cas. Quest Med. 1968;21:476-482.
20. Sampson PD, Streissguth AP, Bookstein FL, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997;56:317-326.
21. Koren G, Nulman I, Chudley AE, et al. Fetal alcohol spectrum disorder. CMAJ. 2003;169:1181-1185.